Drugs / Estradot
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT06704516 | Jan → Aug 2025 overdue | metabolic dysfunction-associated steatotic liver disease | University of Oxford | Recruiting | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01204840 Comparator | Sep 2010 → May 2015 | infertility disorder, ovarian dysfunction | Ottawa Fertility Centre | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Estradot | “Brands of HRT include oestrogel, Evorel, Lenzetto, Estradot, Progynova (this list is not exhaustive)” NCT06704516 ↗1“100ug estrogen patch (Estradot)” NCT01204840 ↗ |
| Route | Other | “100ug estrogen patch (Estradot)” NCT01204840 ↗ |